Balaxi Pharmaceuticals Limited

Informe acción NSEI:BALAXI

Capitalización de mercado: ₹3.9b

Salud financiera de hoja de balance de Balaxi Pharmaceuticals

Salud financiera controles de criterios 4/6

Balaxi Pharmaceuticals tiene un patrimonio de accionistas total de ₹2.2B y una deuda total de ₹303.3M, lo que sitúa su ratio deuda-patrimonio en 14.1%. Sus activos y pasivos totales son ₹2.9B y ₹721.0M respectivamente. El BAIT de Balaxi Pharmaceuticals es de ₹457.0M, por lo que su ratio de cobertura de intereses es de 24.8. Tiene efectivo e inversiones a corto plazo que ascienden a ₹608.7M.

Información clave

14.1%

Ratio deuda-patrimonio

₹303.30m

Deuda

Ratio de cobertura de intereses24.8x
Efectivo₹608.67m
Patrimonio₹2.16b
Total pasivo₹720.97m
Activos totales₹2.88b

Actualizaciones recientes sobre salud financiera

Recent updates

Balaxi Pharmaceuticals (NSE:BALAXI) Strong Profits May Be Masking Some Underlying Issues

Nov 13
Balaxi Pharmaceuticals (NSE:BALAXI) Strong Profits May Be Masking Some Underlying Issues

These 4 Measures Indicate That Balaxi Pharmaceuticals (NSE:BALAXI) Is Using Debt Reasonably Well

Jul 30
These 4 Measures Indicate That Balaxi Pharmaceuticals (NSE:BALAXI) Is Using Debt Reasonably Well

Balaxi Pharmaceuticals Limited's (NSE:BALAXI) Share Price Could Signal Some Risk

May 29
Balaxi Pharmaceuticals Limited's (NSE:BALAXI) Share Price Could Signal Some Risk

Market Might Still Lack Some Conviction On Balaxi Pharmaceuticals Limited (NSE:BALAXI) Even After 38% Share Price Boost

Feb 10
Market Might Still Lack Some Conviction On Balaxi Pharmaceuticals Limited (NSE:BALAXI) Even After 38% Share Price Boost

Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet

Feb 09
Balaxi Pharmaceuticals (NSE:BALAXI) Has A Pretty Healthy Balance Sheet

Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?

Aug 08
Is Balaxi Pharmaceuticals (NSE:BALAXI) A Risky Investment?

The Trend Of High Returns At Balaxi Pharmaceuticals (NSE:BALAXI) Has Us Very Interested

May 20
The Trend Of High Returns At Balaxi Pharmaceuticals (NSE:BALAXI) Has Us Very Interested

A Look At The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Feb 03
A Look At The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Calculating The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Sep 06
Calculating The Intrinsic Value Of Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Balaxi Pharmaceuticals (NSE:BALAXI) Knows How To Allocate Capital Effectively

Jun 03
Balaxi Pharmaceuticals (NSE:BALAXI) Knows How To Allocate Capital Effectively

Is Weakness In Balaxi Pharmaceuticals Limited (NSE:BALAXI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Mar 12
Is Weakness In Balaxi Pharmaceuticals Limited (NSE:BALAXI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Is Balaxi Pharmaceuticals Limited's(NSE:BALAXI) Recent Stock Performance Tethered To Its Strong Fundamentals?

Nov 27
Is Balaxi Pharmaceuticals Limited's(NSE:BALAXI) Recent Stock Performance Tethered To Its Strong Fundamentals?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (₹2.4B) de BALAXI superan a sus pasivos a corto plazo (₹693.2M).

Pasivo a largo plazo: Los activos a corto plazo de BALAXI (₹2.4B) superan a sus pasivos a largo plazo (₹27.7M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: BALAXI tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de BALAXI ha crecido de 0% a 14.1% en los últimos 5 años.

Cobertura de la deuda: El flujo de caja operativo de BALAXI es negativo, por lo que la deuda no está bien cubierta.

Cobertura de intereses: Los pagos de intereses de la deuda de BALAXI están bien cubiertos por el BAIT (24.8x cobertura).


Hoja de balance


Descubre empresas con salud financiera